Autism spectrum disorder M-CHAT Modified Checklist for Autism in Toddlers PPV Positive predictive value AIM The Modified Checklist for Autism in Toddlers (M-CHAT) could be appropriate for universal screening for autism spectrum disorder (ASD) at 18 months and 24 months. Validation studies, however, reported differences in psychometric properties across sample populations. This meta-analysis summarized its accuracy measures and quantified their change in relation to patient and study characteristics.
INTERPRETATION Findings indicate that the M-CHAT performs with low to moderate accuracy in identifying ASD among children with developmental concerns, but there was a lack of evidence on its performance in low-risk children or at age 18 months. Clinicians should account for a child's age and presence of developmental concern when interpreting their M-CHAT score.
The Modified Checklist for Autism in Toddlers (M-CHAT) was designed to screen for autism spectrum disorder (ASD) in children between 16 months and 30 months. 1 Validation studies have reported moderate psychometric properties across various populations, potentially supporting the use of the M-CHAT as part of universal screening. [2] [3] [4] The purpose of ASD screening using a standardized tool is to systematically identify early signs of ASD, and the American Academy of Pediatrics recommends that it should take place at 18 months and 24 months for all children. 5 Whether screening should take place for all children and with which screening tool, however, are currently being debated. 2, 6 The original M-CHAT consists of 23 questions about behaviors that are potential early signs of ASD in very young children. Parents or caregivers complete the checklist on the basis of their child's current skills and behaviors. Its brevity is one of its advantages, as is the fact that it does not require responses based on clinical observation by a trained clinician. A child is considered to be at-risk if they fail more than two of the six critical items (Critical6) or three of the 23 items (Total23) on the checklist. Among the 1293 children screened in the original study, 132 screened positive and 39 were later diagnosed with ASD. The M-CHAT follow-up interview, a 5-to 20-minute structured telephone interview used to confirm items endorsed by the parent, can be performed in addition for children who screen positive before full developmental assessment. The follow-up interview was reported to improve positive predictive value (PPV). 7 A revised with follow-up version, M-CHAT-R/F, excluded three items from the original M-CHAT and was validated in a low-risk sample with a PPV of 0.14. 8 Since its publication in 2001, several studies have estimated the accuracy of the M-CHAT in children with or without developmental concerns screened at different ages. A 'developmental concern' was typically defined as atypical development identified by a physician and leading to referral for diagnostic assessment or behavioral intervention. Previous studies that reviewed the validation studies identified methodological limitations such as high drop-out rates, reporting aggregated results from high-and low-risk children together and a lack of blinding between screening and assessment, which could have biased study findings. 2, 3 As the items on the checklist are related to age-specific development, psychometric properties also varied with age. One study reported that the proportion of positive screens increased with age, particularly in children older than the intended age range of the M-CHAT at 33 to 48 months. 9 Given the heterogeneity in the presentation of ASD symptoms, variation in psychometric properties across study samples can be expected. Among children with ASD, observable variations in sensory, social communication, and repetitive behavior have been reported by the second year of life, but the severity and type of deficits vary by age, cognitive development, and co-occurring conditions. 10, 11 Moreover, subtle delays present at around 12 months might not be ASD-specific and early ASD screening could falsely identify children with other developmental concerns, for example isolated language delay, as having ASD. 4 Quantifying the direction and magnitude by which the accuracy of the M-CHAT differs according to key characteristics (e.g. age at screening, sex of the child) would help determine whether the M-CHAT is appropriate for universal screening. Moreover, understanding how the psychometric properties change could help clinicians interpret an individual's M-CHAT score in relation to their clinical profile. The purpose of this study was to quantitatively summarize the accuracy of the M-CHAT (i.e. sensitivity, specificity, and PPV) in children screened for ASD and to quantify the extent to which these measures of accuracy change in relation to the age at screening, sex distribution, study design, and background risk for ASD.
METHOD

Search strategy
The literature search, data extraction, and statistical analyses were based on the Cochrane guidelines for systematic reviews of diagnostic tests. 12 The literature was searched using Medical Subject Headings and keywords associated with ASD (ASD; Asperger; Asperger syndrome; autistic; autistic disorder; autism spectrum disorder; autism; child development disorders, pervasive; development* AND disorder*) and M-CHAT (M-CHAT, Modified Checklist for Autism in Toddlers) using MEDLINE, Embase, Psyc-INFO, and CINAHL in May 2018 (Appendix S1, online supporting information). After duplicated entries were removed, titles and abstracts of the retrieved articles were assessed by one reviewer. Full texts of selected articles were reviewed on the basis of inclusion criteria. The reference lists of the included articles were scanned for additional articles. This protocol was not registered in PROSPERO.
Selection criteria
Studies were included if they met all of the following inclusion criteria: (1) screened children for ASD using the original M-CHAT; (2) reported the results of screening and clinical diagnosis of the children such that sensitivity, specificity, and PPV could be calculated; (3) sample population was not selected on the basis of any medical condition other than developmental delays (e.g. low birthweight, Down syndrome); and (4) published in English. As three American studies screened a small proportion of children using the Spanish version of the M-CHAT, the language criterion was broadened to include studies that screened more than 90% of children using the English M-CHAT. The two studies that used the M-CHAT-R/F were excluded as results could not be converted to match the original version. Articles published between January 2001, the year of publication of the M-CHAT, and May 2016 were screened. If more than one article used the same study population, only the article with the largest sample size was included. Figure S1 (online supporting information) describes the number of articles retrieved and the reasons for exclusion as recommended by Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). 13 Thirteen studies satisfied all inclusion criteria and were included in this meta-analysis.
Data extraction and quality appraisal
For this meta-analysis, studies based on children with any developmental concerns were categorized as 'high risk', studies on children without identified developmental concerns were categorized as 'low risk', and studies that included both children with and without developmental concerns were categorized as 'mixed'. A positive screen was defined as failing either of the scoring algorithms: Critical6 (failing more than two of the six critical items) and Total23 (failing more than three items on the M-CHAT). 1 Information on publication (author, year of publication, country of study), participants (age, sex, ASD diagnosis, high/low risk), study procedure (method of recruitment, ASD diagnostic criteria, M-CHAT scoring algorithm), and results (number of positive and negative screens, true positive, true negative) were extracted from the included studies using a data collection form. As few studies performed the recommended telephone follow-up interview, 7 the M-CHAT results before follow-up interview were used for the analysis. The corresponding authors were contacted if any information was missing from the publication.
The quality of the included articles was appraised independently by two researchers using the QUADAS-2 (a quality assessment tool for diagnostic accuracy studies). 14 It was modified to better evaluate biases in sample selection, implementation of the M-CHAT, and diagnostic assessment of ASD studies (Appendix S2, online supporting information). Interrater agreement for the initial quality appraisal was quantified using Cohen's kappa (j). Disagreements in assessments were jointly reviewed until a consensus was reached between the two reviewers (TY, MP).
Statistical analysis
The sensitivity and specificity were each pooled using a bivariate hierarchical (random-effects) model under a Bayesian framework. 15, 16 A bivariate model was selected as it could
What this paper adds
• The Modified Checklist for Autism in Toddlers (M-CHAT) performs with lowto-moderate accuracy in children with developmental concerns.
• There is limited evidence supporting its use at 18 months or in low-risk children.
account for the covariance between sensitivity and specificity in each study by jointly estimating the two values. For each study, the numbers of true positive and true negative screens were assumed to follow two binomial distributions. The study-specific values were then transformed on the logit scale and modeled as a bivariate normal distribution.
As the PPV varies depending on the prevalence of the underlying condition, study-specific PPV was standardized using ASD prevalences reflective of a low-risk (in general population, 1 in 68) and a high-risk (mean prevalence across included high-risk studies, 45.6%) population. 17, 18 For studies where sensitivity and specificity could not be calculated, the reported PPVs (i.e. non-standardized) on low-risk children were pooled with PPVs standardized using the low-risk ASD prevalence, and reported PPVs on high-risk children were pooled with PPVs standardized using the high-risk prevalence. The study-specific PPVs were also pooled using a Bayesian hierarchical model.
For the joint sensitivity and specificity model and the PPV regression models, the posterior distributions of the parameters were estimated using single-chain Gibbs sampling of 11 000 replications with the first 1000 iterations discarded. Non-informative prior distributions were used for all parameters, except that a weakly informative scaled inverse Wishart distribution was used for the covariance matrix in the bivariate normal distribution. The estimated study-specific values, pooled estimates, and their 95% credible intervals (CIs) were transformed back to the probability scale and summarized in forest plots. Convergence was assessed graphically and heterogeneity was quantified with an I 2 test. All analyses were conducted in WinBUGS version 1.4.3.
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Investigation of heterogeneity
Meta-regressions were performed to quantify the differences in sensitivity, specificity, and PPV in relation to mean age at screening, proportion of males, and study design (retrospective vs prospective). A regression model was built for each of the three covariates paired with each outcome owing to the low number of studies. Studies with missing covariates were excluded from the meta-regressions. Non-informative normal prior distributions were used for all beta-coefficients in models.
RESULTS
Study characteristics
Tables I and II summarize the characteristics and results of the included studies. All were performed in North America except two. 20, 21 Five retrospective studies collected information using medical records. [21] [22] [23] [24] [25] On average, children were screened at 21 to 41 months, and four studies 20, 21, 23, 26 screened children above the M-CHAT recommended age range. ASD diagnostic assessment was performed at 24 to 52 months. High-risk studies (n=12) had higher proportions of males than females, while lowrisk studies had sex parity. The prevalence of ASD in studies based on children with developmental concerns (range 38%-66%) was higher than that of the general population.
The quality ratings are summarized in Table III . Interrater agreement of the initial assessments between the two reviewers was moderate (j=0.78). Potential sources of bias in participant selection and implementation of M-CHAT and/or ASD diagnosis were identified in all studies. A high risk of selection bias was introduced through volunteer bias from families, as indicated by moderate (50%-60%) survey response rates, or from potential selective referral by participating clinicians. The reported socio-demographic and functional characteristics of the sample populations in 70% of the studies can be considered reflective of children with ASD or developmental concerns typically presented at clinical settings on the basis of clinical opinion. In half of the studies, the interval between M-CHAT screening and clinical diagnosis was not reported or was more than 6 months. High-risk was defined as studies with children with any identified developmental concerns; low-risk refers to studies with children without identified developmental concerns; mixed refers to studies with both high-and low-risk children. Sixty percent of the studies did not include all study participants in sensitivity and specificity calculations, with few providing the reasons for exclusion. Only two studies reported that the interpreter of the M-CHAT was blinded to the child's clinical diagnosis or that the M-CHAT was scored before clinical diagnosis. ASD diagnostic assessments were performed by psychologists and, typically, one or more qualified professional (i.e. psychometrist, developmental pediatrician, occupational therapist, speech language pathologist, or special education teacher). One study did not provide details on diagnostic assessment. 25 Studies on low-risk children One study 7 exclusively focused on low-risk children, and two mixed studies 1, 27 included children without developmental concerns. Only the PPVs were reported in all three studies, as children who screened negative on the M-CHAT did not undergo ASD diagnostic assessment and clinical diagnosis was not established. The PPV ranged from 0.05 to 0.11, but increased to 0.42 to 0.65 if the M-CHAT telephone followup interview was administered.
Studies on high-risk children
Of the 12 studies that included children with developmental concerns, three 20, 23, 28 sampled from children referred for unspecified mental health services, three 1,22,27 from children referred for early behavioral intervention, and six 21,24-27,29 from children referred for diagnostic assessment for developmental conditions. Children were typically screened at 2 to 3 years old, with one study 23 reporting a mean age above 40 months. Clinical diagnosis of ASD was established on average within 6 months after screening in seven studies 1, 7, 23, 26, 27, 29, 30 and was not reported by three. 22, 24, 28 Without the telephone interview, the sensitivity ranged from 0.64 to 0.96, specificity from 0.27 to 0.67, and PPV from 0.53 to 0.83.
Sensitivity and specificity
The study-specific and pooled sensitivity and specificity are summarized in Figure 1 . On the basis of the nine studies where sensitivity and specificity could be calculated, heterogeneity was high (I 2 >90 for either measure), the pooled sensitivity was 0.83 (95% CI 0.75-0.90), and pooled specificity was 0.51 (95% CI 0.41-0.61). Specificity was comparable across different ages at screening but sensitivity was higher at 30 months (sensitivity: 0.69, 95% CI 0.19-0.86; specificity: 0.46, 95% CI 0.03-0.64) compared with 24 months (sensitivity: 0.55, 95% CI 0.02-0.84; specificity: 0.45, 95% CI <0.01-0.71). No meaningful differences were observed in the sensitivity and specificity Values might differ from the original papers because of differences in reporting (e.g. disaggregation by scoring method, age group, etc.). Positive predictive ratios indicate the ratio of true positives to total positives. Additional information was provided by corresponding authors. Critical6: positive screen defined as failing more than two of the six critical items. Total23: positive screen defined as failing more than three items of the 23 items. Both scoring algorithms were used for all other studies (i.e. a positive screen defined as failing more than two of the critical six items and/or more than three of any 23 items). between retrospective and prospective studies or between low and high proportions of males.
PPV
The PPVs from nine studies were standardized using the ASD prevalence in the general population 17 and pooled with the reported PPVs on low-risk children from three studies. 1, 7, 27 The pooled PPV in low-risk children was 0.06 (95% CI <0.01-0.14). A large difference was estimated between the PPVs standardized using ASD prevalence in the general population (0.01, 95% CI <0.01-0.09) and reported PPV in low-risk children that could not be standardized (0.20, 95% CI 0.07-0.33). When the PPVs were standardized using the mean ASD prevalence across the included high-risk studies (45.6%) and combined with the reported PPV on high-risk children from three studies, 1, 7, 27 the pooled PPV was 0.53 (95% CI 0.43-0.63). There was minimal difference between the standardized and non-standardized high-risk PPVs.
Given the high variability across PPVs in low-risk children, only high-risk PPVs were analyzed using metaregressions. The point estimate of the PPV in high-risk children decreased as the proportion of males increased (75% male: 0.58, 95% CI 0.52-0.64; 100% male: 0.46, 95% CI 0.14-0.78) but the credible intervals overlapped. There were no clinically relevant differences in PPV by age at screening or study design.
DISCUSSION
This meta-analysis quantitatively summarized the accuracy of the M-CHAT. The findings indicate that the M-CHAT can identify ASD with moderate sensitivity and low specificity among children with developmental concerns. However, sensitivity and specificity could not be calculated for low-risk children because studies that included children without developmental concerns did not establish clinical diagnosis for those who screened negative on the M-CHAT. The accuracy of the M-CHAT at 18 months, although within the intended age range of the M-CHAT, 1 could not be precisely predicted in this meta-analysis as few studies screened 18-month-old children. In turn, there is a lack of evidence supporting its use as part of universal screening for ASD at 18 months and 24 months.
The low pooled specificity of the M-CHAT in high-risk children suggests that if all screen-positive children were referred for ASD diagnostic assessment, there would be a Ringwood 24 Snow and Lecavalier 26 Goodwin 23 Fessenden 28 Charman et al. 20 Koh et al. 21 Eaves 29 Salisbury et al. 25 Cogan-Ferchalk 22 Pooled sensitivity 0.5 Koh et al. 21 Cogan-Ferchalk 22 Fessenden 28 Salisbury et al. 25 Goodwin 23 Eaves 29 Charman et al. 20 Snow and Lecavalier 26 Ringwood Review 1097 high proportion of children who needlessly undergo lengthy assessment because of false-positive screens. This would decrease the efficiency of the diagnostic pathway by prolonging wait times for children who truly require indepth assessment and increasing healthcare expenditures. Studies have reported that some children screened positive on the M-CHAT had developmental disorders other than ASD and would benefit from further assessment. 31, 32 The M-CHAT, however, was not designed for identifying general developmental concerns and there may be other screening tools more suited for this purpose. While the pooled sensitivity in high-risk children is in the moderate range, the consequences of a false-negative screen could be severe if it delays ASD diagnosis and timely access to appropriate interventions.
Methodological issues were identified in all studies, which could have biased reported accuracy measures. In particular, potential selective referral by participating clinicians, lack of blinding between M-CHAT scoring and clinical diagnosis, and limited details on diagnostic assessment were consistently noted. Lack of blinding could have led to overestimation of the reported accuracy measures as clinicians may be more inclined to diagnose a child with ASD after learning the child's positive screen result. Moreover, knowing a child's clinical diagnosis before scoring the M-CHAT is contrary to the purpose of screening. The inconsistent and often long intervals between screening and diagnosis were also a source of concern, especially considering the rapid development that occurs in toddlers. The need to validate the M-CHAT in distinct study populations is also critical. Two of the larger M-CHAT studies, 31, 32 for example, used individuals who also participated in studies that were included in this meta-analysis. 7, 27 To maximize the number of studies included, one of which provided the needed input used to estimate the pooled sensitivity and specificity in high-risk children, we chose to include the two smaller studies. Moreover, these larger studies only screened a large number of children initially, but the reported accuracy measures were estimated from the very small subset of children with a clinical diagnosis. While only following up on children with a negative M-CHAT screen may be an efficient study design, this greatly reduces the statistical power to detect an effect size. An additional 15 studies were excluded because study results were not reported in a manner that could be included in the meta-analysis. Standardizing how findings are reported (e.g. using the recommended M-CHAT scoring algorithms to determine screening results, using clinical diagnosis as the comparison standard, calculating accuracy measures using standard formulas) would facilitate cross-study comparison to determine where evidence gaps are.
Findings from the meta-regressions indicate that clinicians should consider the child's age and presence of developmental concern when interpreting their M-CHAT score. The lack of a clinically relevant difference between high and low proportions of males is reassuring, as it suggests that the M-CHAT can accurately identify ASD both in males and in females. Standardized PPVs were sensitive to changes in ASD prevalence and the pooled value was only slightly higher than the pre-test odds in both low-and high-risk populations. The difference between reported PPVs in low-risk children and PPV standardized using the ASD prevalence in the general population suggests that the children in low-risk studies might not be truly low risk or representative of the general population. Moreover, the prevalence of ASD among toddlers may be lower than the Centers for Disease Control and Prevention prevalence, and standardization using a lower prevalence would further magnify the difference between the PPV among low-and high-risk children. Sensitivity, specificity, and negative predictive value could not be calculated for low-risk children as clinical assessment was not performed for those who passed M-CHAT screening. Future studies need to ensure that all children screened are followed up for an appropriate duration and that clinical diagnosis (i.e. the comparison standard) is established. Evidence on the psychometric properties of the M-CHAT, or another ASD screening tool, in both low-and high-risk populations is critical to determine whether it is appropriate for use on a population level or as part of universal screening.
The M-CHAT-R/F 8 reports greater PPV, but it also requires a structured telephone interview after a positive screen. Implementation of screening with a standardized tool is already low in clinical settings. 33, 34 The additional follow-up interview would probably further reduce uptake or compliance with protocol, which would decrease accuracy of screening. This disconnect between recommended protocol and clinical feasibility was evident in some of the included studies that failed to perform the follow-up interview for the original M-CHAT. 7 In turn, this meta-analysis did not include results from the follow-up interview, despite it being a recommended step that could have increased the pooled PPV.
Given these limitations, the use of a standardized ASD tool (e.g. the M-CHAT) might be more appropriate as a second-line screen, in addition to routine check-up, by primary care physicians for children with developmental concerns to better guide the course of follow-up assessment. Routine developmental surveillance, on the other hand, remains a critical and recommended component of routine check-ups to identify any signs of developmental concerns over time. 6, 35 Limitations While this meta-analysis was performed in accordance with the Cochrane guidelines, 12 there are limitations. First, the diagnostic criteria for ASD have changed from the Diagnostic and Statistical Manual of Mental Disorders (DSM) IV to 5, 36 and validation studies reported that children with severe ASD remain on the spectrum but that some with milder symptoms or those without repetitive behavior do not. 37, 38 In turn, the reported PPV and sensitivity could be lower using the DSM-5 criteria, as children with milder symptoms who screened positive may be less likely to be ultimately diagnosed with ASD. Variations in ASD diagnostic criteria and the type of clinician who performed the assessment contributed to between-study heterogeneity. However, the lack of a criterion standard is inherent in psychiatry and the methods reported in most studies could be considered reflective of clinical practice. Another limitation is that only studies that primarily used the English version of the M-CHAT were included. The heterogeneity across studies that validated the M-CHAT in other languages and countries [39] [40] [41] was too great be pooled in a meta-analysis but their findings may have strengthened conclusions from this study. For example, one study 42 that screened 52 026 low-risk children using the Norwegian translation of the M-CHAT concluded that more than one-third of the children later diagnosed with ASD were not captured by the M-CHAT (i.e. passed screening) at 18 months. Comparison of its performance across ethnocultural groups is necessary to ensure that it can correctly identify children with ASD across the general population. Since there were only two validation studies using the M-CHAT-R/F at the time of this meta-analysis, the accuracy of the revised version, although often used clinically, could not be summarized. Although five of the 13 included studies were dissertations, there were no indications that these studies were of lower quality than the peer-reviewed studies.
CONCLUSION
This meta-analysis provided quantitative evidence that the M-CHAT performs with moderate sensitivity and low specificity in children with developmental concerns. Although the intended use of the M-CHAT coincides with universal screening at 18 months and 24 months, there was a lack of evidence on its accuracy in low-risk children or at age 18 months. Identified heterogeneity in accuracy measures emphasizes that clinicians should account for a child's age and presence of developmental concern when interpreting their M-CHAT score. Validation studies with methodological rigor both in low-and high-risk children are needed before the M-CHAT can be recommended for use on a population-level.
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RESUMEN
